» Articles » PMID: 32382743

COVID-19 Testing, Epidemic Features, Hospital Outcomes, and Household Prevalence, New York State-March 2020

Abstract

Background: The US' coronavirus disease 2019 (COVID-19) epidemic has grown extensively since February 2020, with substantial associated hospitalizations and mortality; New York State has emerged as the national epicenter. We report on the extent of testing and test results during the month of March in New York State, along with risk factors, outcomes, and household prevalence among initial cases subject to in-depth investigations.

Methods: Specimen collection for COVID-19 testing was conducted in healthcare settings, community-based collection sites, and by home testing teams. Information on demographics, risk factors, and hospital outcomes of cases was obtained through epidemiological investigations and an electronic medical records match, and summarized descriptively. Active testing of initial case's households enabled estimation of household prevalence.

Results: During March in New York State, outside of New York City, a total of 47 326 persons tested positive for severe acute respiratory syndrome coronavirus 2, out of 141 495 tests (33% test-positive), with the highest number of cases located in the metropolitan region counties. Among 229 initial cases diagnosed through 12 March, by 30 March 13% were hospitalized and 2% died. Testing conducted among 498 members of these case's households found prevalent infection among 57%, excluding first-reported cases 38%. In these homes, we found a significant age gradient in prevalence, from 23% among those < 5 years to 68% among those ≥ 65 years (P < .0001).

Conclusions: New York State faced a substantial and increasing COVID-19 outbreak during March 2020. The earliest cases had high levels of infection in their households and by the end of the month, the risks of hospitalization and death were high.

Citing Articles

Spatial distribution of SARS-CoV-2 incidence, social inequality, housing conditions, and density in South-Eastern France: keys for future epidemics.

Marine Barjoan E, Prouvost-Keller B, Chaarana A, Festraets J, Geloen C, Legueult K Front Public Health. 2024; 12:1422112.

PMID: 39712297 PMC: 11659207. DOI: 10.3389/fpubh.2024.1422112.


Susceptibility and infectiousness of SARS-CoV-2 in children versus adults, by variant (wild-type, alpha, delta): A systematic review and meta-analysis of household contact studies.

Uthman O, Lyngse F, Anjorin S, Hauer B, Hakki S, Martinez D PLoS One. 2024; 19(9):e0306740.

PMID: 39240908 PMC: 11379298. DOI: 10.1371/journal.pone.0306740.


Inferring COVID-19 testing and vaccination behavior from New Jersey testing data.

Freedman A, Sheen J, Tsai S, Yao J, Lifshitz E, Adinaro D Proc Natl Acad Sci U S A. 2024; 121(17):e2314357121.

PMID: 38630720 PMC: 11047110. DOI: 10.1073/pnas.2314357121.


Preventable Emergency Department Visits of Patients with Alzheimer's Disease and Related Dementias During the COVID-19 Pandemic by Hospital-Based Health Information Exchange.

Wang N, Maguire T, Chen J Gerontol Geriatr Med. 2024; 10:23337214241244984.

PMID: 38585042 PMC: 10998440. DOI: 10.1177/23337214241244984.


Mitigation through on-site testing & education among formerly incarcerated individuals against Covid-19 - The MOSAIC study: Design and rationale.

Ackerman M, Holmes C, Antigua J, Riback L, Zhang C, Walker J Contemp Clin Trials. 2023; 136:107406.

PMID: 38097063 PMC: 11055630. DOI: 10.1016/j.cct.2023.107406.